You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

RYTHMOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rythmol, and what generic alternatives are available?

Rythmol is a drug marketed by Glaxosmithkline Llc and is included in two NDAs.

The generic ingredient in RYTHMOL is propafenone hydrochloride. There are eleven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rythmol

A generic version of RYTHMOL was approved as propafenone hydrochloride by WATSON LABS on October 24th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RYTHMOL?
  • What are the global sales for RYTHMOL?
  • What is Average Wholesale Price for RYTHMOL?
Summary for RYTHMOL
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 181
Clinical Trials: 2
Patent Applications: 4,007
Drug Prices: Drug price information for RYTHMOL
What excipients (inactive ingredients) are in RYTHMOL?RYTHMOL excipients list
DailyMed Link:RYTHMOL at DailyMed
Drug patent expirations by year for RYTHMOL
Drug Prices for RYTHMOL

See drug prices for RYTHMOL

Recent Clinical Trials for RYTHMOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 1
Mayo ClinicPhase 3
MedtronicPhase 3

See all RYTHMOL clinical trials

US Patents and Regulatory Information for RYTHMOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc RYTHMOL propafenone hydrochloride TABLET;ORAL 019151-001 Nov 27, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline Llc RYTHMOL SR propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021416-001 Sep 4, 2003 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline Llc RYTHMOL propafenone hydrochloride TABLET;ORAL 019151-003 Nov 20, 1992 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline Llc RYTHMOL propafenone hydrochloride TABLET;ORAL 019151-002 Nov 27, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.